Ben Freeberg
Founder and Managing Partner @ Oncology Ventures
New York, United States
Ben Freeberg is a seed investor at Oncology Ventures in New York focused on Medical and Health Care. Ben Freeberg is based out of New York and is the Founder and Managing Partner of Oncology Ventures. Ben previously worked at Thyme Care as an Advisor. Ben Freeberg attended Duke University.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 27%
Last updated:
For AI agents: llms.txt
Industries Ben Freeberg invests in
Stages Ben Freeberg invests in
Countries Ben Freeberg invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 4 (36%)
- Health Care 4 (36%)
- Artificial Intelligence 3 (27%)
- Software 2 (18%)
- Biopharma 2 (18%)
Stage
- Seed 4 (36%)
- Series A 3 (27%)
- Venture - Series Unknown 2 (18%)
- Pre-Seed 1 (9%)
- Series B 1 (9%)
Country
- United States 7 (64%)
- Argentina 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Bringing Self-Service AI to the Life Sciences | $4.5M / Seed / May 06, 2026 | ||
| NexCure offers clinically intense therapies in outpatient, community settings, revolutionizing the delivery, monitoring, and scaling of CAR-T and other cutting-edge treatments. | $19M / Series A / Mar 05, 2026 | ||
| CancerNavigator offers cancer navigation and analytics, connecting patients with care experts and providing personalized support. | $7M / Venture - Series Unknown / Feb 18, 2026 | ||
| We exist for humanity 2Win. Pioneering BOSS [Business (Operating System) as Service]. Trusted by Top Oncologists, we serve mission critical enterprises. Transforming key operations with AI-driven discipline. Headquartered in Silicon Valley, RISA has offices across the globe. | $11.1M / Series A / Jan 13, 2026 | ||
| BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment. | $8M / Series A / Jan 12, 2026 | ||
| Lumonous is a healthcare company that offers Radiation Oncology, Radiation Therapy, and Cancer treatment technology-enabled services. | $18.2M / Series B / Nov 06, 2025 | ||
| heva is a vertical SaaS AI platform for doctors serving medical tourists. | $3.1M / Pre-Seed / Apr 25, 2025 | ||
| We exist for humanity 2Win. Pioneering BOSS [Business (Operating System) as Service]. Trusted by Top Oncologists, we serve mission critical enterprises. Transforming key operations with AI-driven discipline. Headquartered in Silicon Valley, RISA has offices across the globe. | $3.5M / Seed / Apr 17, 2025 | ||
| Daymark Health is a cancer care company that focuses on providing in-home and virtual supportive care to cancer patients in collaboration with health plans. The company offers a wide range of supportive care services, including behavioral health care and social support, aimed at meeting the comprehensive needs of cancer patients. Daymark Healthconnects primary care physicians, oncologists, and other care teams to create a seamless and supportive experience for patients, leveraging both virtual and home-based care methodologies. | $11.5M / Seed / Apr 03, 2025 | ||
| DHN Solution is a cloud-based automation software platform that helps healthcare systems to improve their preventive care quality metrics. . | $1M / Seed / Oct 21, 2024 | ||
| See all 11 investments → | |||
Co-Investors
About Oncology Ventures
Oncology Ventures will make investments in cancer-focused data, infrastructure, IT, and services start-ups with the goal of fundamentally changing the way cancer treatment is conceived and provided at scale. Our fund will not invest in pharmaceuticals, therapies, or medical devices.
Oncology Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ben Freeberg
Founder and Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ben Freeberg invest in?
Ben Freeberg invests primarily in Medical, Health Care and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ben Freeberg?
Public channels for Ben Freeberg include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ben Freeberg last invest?
The most recent investment recorded for Ben Freeberg closed in May 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
